- Home
- IOVA vs CON Comparison
IOVA vs CON Comparison
Compare IOVA & CON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- CON
- Stock Information
- Founded
- IOVA 2007
- CON 1979
- Country
- IOVA United States
- CON United States
- Employees
- IOVA N/A
- CON N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- CON
- Sector
- IOVA Health Care
- CON
- Exchange
- IOVA Nasdaq
- CON NYSE
- Market Cap
- IOVA 2.6B
- CON 2.6B
- IPO Year
- IOVA N/A
- CON 2024
- Fundamental
- Price
- IOVA $5.91
- CON $21.13
- Analyst Decision
- IOVA Strong Buy
- CON Strong Buy
- Analyst Count
- IOVA 9
- CON 7
- Target Price
- IOVA $23.33
- CON $28.71
- AVG Volume (30 Days)
- IOVA 9.1M
- CON 740.3K
- Earning Date
- IOVA 02-26-2025
- CON 02-15-2025
- Dividend Yield
- IOVA N/A
- CON 1.18%
- EPS Growth
- IOVA N/A
- CON 0.28
- EPS
- IOVA N/A
- CON 1.59
- Revenue
- IOVA $90,858,000.00
- CON $1,875,891,000.00
- Revenue This Year
- IOVA $13,758.71
- CON $4.29
- Revenue Next Year
- IOVA $171.20
- CON $5.63
- P/E Ratio
- IOVA N/A
- CON $13.26
- Revenue Growth
- IOVA 12751.20
- CON 8.79
- 52 Week Low
- IOVA $5.62
- CON $18.89
- 52 Week High
- IOVA $18.33
- CON $24.81
- Technical
- Relative Strength Index (RSI)
- IOVA 28.87
- CON N/A
- Support Level
- IOVA $5.62
- CON N/A
- Resistance Level
- IOVA $6.44
- CON N/A
- Average True Range (ATR)
- IOVA 0.45
- CON 0.00
- MACD
- IOVA -0.10
- CON 0.00
- Stochastic Oscillator
- IOVA 11.46
- CON 0.00
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About CON CONCENTRA GROUP HOLDINGS PARENT INC
Concentra Group Holdings Parent Inc is a company providing occupational and consumer health services through occupational health centers and onsite clinics. Their services include workers' compensation injury care, employer services, urgent care, clinical testing, wellness programs, and preventative care.